Latest News

A selection of recent news and views from Catapult Ventures follows...

Manchester Imaging teams up with Michelson Diagnostics

Michelson Diagnostics Ltd, manufacturer of the world-leading VivoSight™ OCT skin imaging and measurement system, has teamed up with AI specialists Manchester Imaging Ltd, to aid dermatologists in the fight against skin cancer and o...

Oxford BioTherapeutics Designates Second Bispecific Antibody Program Leveraging WuXi Biologics’ WuXiBody® Platform

OXFORD, United Kingdom and SAN JOSE, Calif. and SHANGHAI, China, Jan. 19, 2021 (GLOBE NEWSWIRE) -- WuXi Biologics (“WuXi Bio”) (2269.HK), a global company with leading open-access biologics technology platforms, and Oxford BioTherapeut...

Maxwellia Announces Appointment of Jack Grimshaw as Finance Director

Maxwellia, the UK’s only dedicated expert medicines switching company, has appointed Jack Grimshaw as Finance Director, with broader accountability for Supply Chain & Logistics, Procurement, IT, Legal & HR. The appointment is a...

Funding package announced for blister prevention firm Pellitec

The North West entrepreneurs behind PelliTec®, the innovative blister prevention pad, are celebrating as the National Institute of Health Research has awarded the company a grant to progress a ‘proof of concept’ study at Sheffield...

Kite and Oxford Biotherapeutics Establish Cell therapy Research Collaboration in Blood Cancers and Solid Tumours

Santa Monica, Calif.; Oxford, UK; and San Jose, Calif., January 6, 2021 - Kite, a Gilead Company (Nasdaq: GILD), and Oxford BioTherapeutics Ltd. (OBT), a clinical stage oncology company with a pipeline of immuno-oncology (IO) and antibody-drug con...

From our portfolio

INFEX Therapeutics


Based at Alderley Park, INFEX Therapeutics aims to tackle the urgent global threat from antimicro...

viewview our portfolio

Our Team

Rob Carroll

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
LE19 4XT

Tel: 0116 238 8200